Funding Rounds
LoQus23

LoQus23 Series A Round, October 2024

LoQus23

LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $43.00M

Raised Date: 2024-10-02